S100A2 antibody (full length)

Catalog No. ABIN7878957

The Mouse Monoclonal anti-S100A2 antibody is suitable to detect S100A2 in samples from Human. It has been validated for ELISA.

Quick Overview for S100A2 antibody (full length) (ABIN7878957)

Target: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This S100A2 antibody is un-conjugated

Application: ELISA

Clone: RS100A2-6482

Product Details anti-S100A2 Antibody

Binding Specificity: full length

Purpose: S100 Calcium Binding Protein A2 Antibody / S100A2

Purification: Protein A/G affinity

Immunogen: Recombinant full-length human protein was used as the immunogen for the S100 Calcium Binding Protein A2 antibody.

Isotype: IgG2b

Application Details

Application Notes: Optimal dilution of the S100 Calcium Binding Protein A2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the S100 Calcium Binding Protein A2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for S100A2

Target: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Alternative Name: S100 Calcium Binding Protein A2

Background: S100A2 belongs to the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100A2 may function as a modulator against excess calcium accumulation in normal human mammary epithelial cells and also have a role in suppressing tumor cell growth. This protein may have a tumor suppressor function. Chromosomal rearrangements and altered expression of this gene have been implicated in breast cancer. Cytoplasmic overexpression may also be of prognostic significance when observed in oral cancer patients, and the S100A2 has also been identified as significantly down regulated in gastric cancer.

UniProt: P29034

Pathways: S100 Proteins